Tirzepatide Side Effects: Safety Signals and Warnings
Tirzepatide safety concerns are compound-specific. The main listed side effects are Nausea, Diarrhea, and Decreased appetite. The main warning signals are Boxed warning: thyroid C-cell tumors in rodents, Contraindicated with MTC history, and Pancreatitis risk.
Direct Answer
Tirzepatide is now the default evidence-backed winner for weight loss among approved incretin drugs: SURMOUNT-5 showed greater weight reduction than semaglutide, and Zepbound also has an FDA indication for moderate-to-severe OSA in adults with obesity. Semaglutide still leads on mature cardiovascular outcomes evidence, but tirzepatide leads on weight-loss magnitude.
- Evidence grade
- Level A
- Research status
- FDA Approved
- Category
- Weight Loss & Metabolic
- Best for
- Obesity, type 2 diabetes, obstructive sleep apnea with obesity, metabolic syndrome research
Reported Side Effects
- Nausea
- Diarrhea
- Decreased appetite
- Vomiting
- Constipation
- Dyspepsia
- Abdominal pain
- Injection site reactions
Warnings
- Boxed warning: thyroid C-cell tumors in rodents
- Contraindicated with MTC history
- Pancreatitis risk
- Hypoglycemia with insulin or sulfonylureas
- Not studied in severe GI disease
Known or Plausible Interactions
- Insulin (dose reduction may be needed)
- Sulfonylureas (hypoglycemia risk)
- Oral contraceptives (may reduce effectiveness)
- Oral medications (absorption may be affected)
Regulatory Context
FDA-approved for type 2 diabetes (Mounjaro, 2022), chronic weight management (Zepbound, 2023), and moderate-to-severe obstructive sleep apnea in adults with obesity (Zepbound, December 20, 2024). Prescription required. Availability may be limited due to high demand.
Evidence Snapshot
| Evidence grade | Level A |
|---|---|
| Research status | FDA Approved |
| Best supported outcomes | Weight Loss (Level A), Blood Sugar Control (Level A), Obstructive Sleep Apnea (Level A), and GI Side Effects (Level A) |
| Primary citation count | 4 |
| Last reviewed | 2026-06-01 |
Related Guides
How to Cite This Page
ExaminePeptides. "Tirzepatide Side Effects: Safety Signals and Warnings." Last reviewed 2026-06-01. https://examinepeptides.com/answers/tirzepatide-side-effects-safety/
This static answer page is built for fast indexing and direct citation. It summarizes the matching full evidence review and links back to primary sources where the source database includes them.